Canine Atopic Dermatitis Market: One of the Major Allergic Conditions in Dogs
- Atopic dermatitis is an allergic, inflammatory, chronic skin disease in dogs caused due to harmless substances such as grass, mold spores, house dust mites, and other environmental allergens
- Symptoms of this allergic disease include excessive scratching, itching, skin inflammation, and rubbing & licking majorly around the face, paws, and underarms.
Read Report Overview -
https://www.transparencymarketresearch.com/canine-atopic-dermatitis-market.html
- Generally, family history of skin allergies in dogs increases susceptibility to various allergens such as animal danders, airborne pollens, mold spores, and house dust mite
- Not a single treatment is 100% effective in curing atopic dermatitis, but most patients need core and supportive therapies
Key Drivers and Restraints of Global Canine Atopic Dermatitis Market
- Rise in prevalence of canine atopic dermatitis is a major factor boosting the growth of the global canine atopic dermatitis market.
- A study published in DataSavant in 2007 indicated that prevalence of canine atopic dermatitis in general clinical populations ranges from 3% to 15%, while in some cases it is up to 30%
- Rise in awareness about early signs & symptoms of allergic reaction in animals and development of advanced therapeutic methods to control symptoms are the other factors fueling the growth of the global canine atopic dermatitis market
- Rise in pollution associated with allergens level is also one of the key factors driving the global market.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=74889
Drug-induced Severe Hypersensitivity Reactions Hamper Market
- Several drugs cause serious adverse reactions which can further alleviate allergic reaction. This restrains the global canine atopic dermatitis market.
- Improper management of canine atopic dermatitis in terms of dosage, administration of drugs, and drug combination can also hamper the growth of the global market
Immunotherapy: Gold Standard for Allergy Therapy
- Based on pharmacotherapy, the global canine atopic dermatitis market can be segmented into immunotherapy, cyclosporine, oclacitinib, canine atopic dermatitis immunotherapeutic (CADI), and others
- Immunotherapy is the more popular treatment for canine atopic dermatitis, as it is the only therapy capable of changing the immune system’s response to allergies rather than suppressing the immune system or dulling the clinical signs and prevention of development of new allergies
- CADI is likely to be a highly lucrative segment in the next few years due to its better action by monoclonal antibody activity that targets IL-31 and rise in demand among most veterinary dermatologists
Request for TOC @
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=74889
Injectable to be Highly Promising Segment
- In terms of route of administration, the global canine atopic dermatitis market can be divided into oral, injectable, and topical
- Injectable is expected to be a highly lucrative segment during the forecast period. Injectables in dogs are majorly administered subcutaneously.
- This route of administration is gaining popularity. The segment is anticipated to expand at a significant CAGR during the forecast period owing to increase in owner’s preference for once a month injection dose rather than twice daily oral medication.
Veterinary Hospitals to be Dominant Segment
- Based on distribution channel, the global canine atopic dermatitis market can be classified into veterinary hospitals, pet clinics, pharmacies & drug stores, and others
- The veterinary hospitals segment dominated the global market due to increase in number of admissions of pets into veterinary hospitals, availability of advanced therapies, and proper use of medications through expert consultation at these settings.
Pre Book Canine Atopic Dermatitis Market Report at
https://www.transparencymarketresearch.com/checkout.php?rep_id=74889<ype=S
North America to Lead Global Canine Atopic Dermatitis Market
- In terms of region, the global canine atopic dermatitis market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America dominated the global canine atopic dermatitis market in 2018 owing to higher prevalence of canine atopic dermatitis, better health care facilities for veterinary care, and development of new therapies & drugs for these animal diseases.
- According to the American Pet Products Association, pet owners in the U.S. spent more than US$ 7.4 Bn on pet care in 2017, while the expenditure in Europe stood at US$ 6.1 Bn for the same year.
Key Manufacturers Operating in Global Canine Atopic Dermatitis Market
Key manufacturers operating in the global market are:
- Zoetis
- Virbac
- Novartis AG
- Boehringer Ingelheim International GmbH
- AB Science
- TORAY INDUSTRIES, INC.
- Elanco
- Bimeda, Inc.
- Vetoquinol S.A.
- Ceva
More Trending Reports by Transparency Market Research –
Vascular Closure Devices Market:
Vessel Sealing Devices Market:
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
